Medical
The Evolving Global Landscape in Vaccine Development: Novotech and Endpoints News Webinar
Novotech, the leading Asia Pacific centred biotech CRO with extensive experience in vaccine trials, is convening an expert panel webinar covering the evolving landscape...
Medical
Novotech Global Report: Robust Phase 1 Trial Growth Across Asia Pacific
Novotech, the leading Asia Pacific centred biotech CRO, has published a new global report on Phase 1 trial activity including current metrics on fast...
Medical
Asia Pacific Cell & Gene Research: Novotech is Growing 50% Faster than ROW
Novotech, the leading Asia Pacific focused biotech specialist CRO and recipient of the Asia Pacific Cell & Gene Therapy Clinical Trials Excellence award, said...
Medical
Novotech Acquires European CRO, Strengthens Global Operations
Novotech announced today the acquisition of EastHORN, a European CRO with clinical, medical and regulatory expertise in multiple strategically important locations across the continent....
Medical
Novotech Acquires US-based Drug Development Consulting Firm, CBR International
Expands Drug Development and FDA Regulatory Expertise Novotech, the leading Asia Pacific-centered biotech CRO today announced the acquisition of CBR International, a global product...
Medical
Novotech is Gold Sponsor at Biotech Showcase 2023
Novotech, the Asia Pacific centered biotech specialist CRO is proud to be Gold Sponsor at Biotech Showcase 2023. Novotech CEO Dr. John Moller and...
Medical
Data Shows 50% of New Trials Have Sites in Asia Pacific
Novotech, the Asia Pacific centered biotech specialist CRO said the latest industry research publication by GlobalData and Novotech found almost 50% of new trials...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
